Arrowpoint Investment Partners (Singapore) Pte. Ltd. United Therapeutics Corp Transaction History
Arrowpoint Investment Partners (Singapore) Pte. Ltd.
- $100 Billion
- Q3 2025
A detailed history of Arrowpoint Investment Partners (Singapore) Pte. Ltd. transactions in United Therapeutics Corp stock. As of the latest transaction made, Arrowpoint Investment Partners (Singapore) Pte. Ltd. holds 2,500 shares of UTHR stock, worth $1.17 Million. This represents 1.07% of its overall portfolio holdings.
Number of Shares
2,500Holding current value
$1.17 Million% of portfolio
1.07%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding UTHR
# of Institutions
807Shares Held
41.4MCall Options Held
1.56MPut Options Held
2.87M-
Black Rock Inc. New York, NY5.47MShares$2.55 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.42MShares$2.06 Billion0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.17MShares$1.01 Billion1.29% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.02MShares$943 Million11.58% of portfolio
-
State Street Corp Boston, MA1.92MShares$897 Million0.03% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $21.2B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...